Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers Nasdaq:IMMU

Media coverage

• Title	Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers Nasdaq:IMMU
  Media name/outlet	Global English (Middle East and North Africa Financial Network)
  Country	Jordan
  Date	9/18/20
  Persons	Andrew Brenner

• Title	Encouraging Early Stage Clinical Results with Trodelvy(TM) in Brain Cancers
  Media name/outlet	Market News Publishing
  Country	United States
  Date	9/18/20
  Persons	Andrew Brenner

• Title	Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy(TM) in Brain Cancers
  Media name/outlet	Chase
  Country	United States
  Date	9/18/20
  Persons	Andrew Brenner

• Title	IMMUNOMEDICS : Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
  Media name/outlet	MarketScreener.com
  Country	United States
  Date	9/18/20
  Persons	Andrew Brenner

• Title	Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy„¢ in Brain Cancers; Results include partial responses in small cohort of patients with brain metastasis from breast cancer (BMBC) and recurrent glioblastoma (rGBM)
  Media name/outlet	PrimeNewswire (Top News)
  Country	United States
  Date	9/18/20
  Persons	Andrew Brenner